Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
0.00%
OPERATING MARGIN AVG 20Y
1.10%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Dyne Therapeutics, Inc.
Market Cap
$2.83B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.82B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
Market Cap
$2.74B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.72B
Operating Margin
11.12%
TTM Avg
10.91%
3Y Avg
6.08%
5Y Avg
-3.97%
Market Cap
$2.69B
Operating Margin
10.06%
TTM Avg
14.13%
3Y Avg
15.87%
5Y Avg
13.57%
Market Cap
$2.66B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$3.04B
Operating Margin
0.00%
TTM Avg
-180.11%
3Y Avg
-313.94%
5Y Avg
-1209.42%
Market Cap
$2.55B
Operating Margin
-42.22%
TTM Avg
-21.11%
3Y Avg
-21.11%
5Y Avg
-21.11%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.83B | 0.00% | 0.00% | 0.00% | 0.00% |
| AtriCure, Inc. (ATRC)vs › | $2.83B | 2.44% | -4.62% | -7.21% | -5.02% |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 12.21% | 13.21% | -4.78% | -42.05% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.74B | 0.00% | 0.00% | 0.00% | 0.00% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.72B | 11.12% | 10.91% | 6.08% | -3.97% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 10.06% | 14.13% | 15.87% | 13.57% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.66B | -274.57% | -464.41% | -382.79% | -92575.80% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.04B | 0.00% | -180.11% | -313.94% | -1209.42% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.55B | -42.22% | -21.11% | -21.11% | -21.11% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.11B | 0.00% | 0.00% | -93.42% | -160.46% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2017-12-31 | -99.36% |
| 2017-09-30 | 31.87% |
| 2017-06-30 | 11.05% |
| 2017-03-31 | -28.00% |
| 2016-12-31 | 4.30% |
| 2016-09-30 | -48.55% |
| 2016-06-30 | -332.53% |
| 2016-03-31 | 86.31% |
| 2015-12-31 | -5.99% |
| 2015-09-30 | 17.12% |
| 2015-06-30 | 0.62% |
| 2015-03-31 | -0.16% |
| 2014-12-31 | 2.11% |
| 2014-09-30 | 3.58% |
| 2014-06-30 | -30.71% |
| 2014-03-31 | 0.13% |
| 2013-12-31 | -3566.67% |
| 2013-09-30 | 3.36% |
| 2013-06-30 | -36.88% |
| 2013-03-31 | -36.16% |
| 2012-12-31 | 237.50% |
| 2012-09-30 | 126.85% |
| 2012-06-30 | -504.55% |
| 2012-03-31 | -32.77% |
| 2011-12-31 | -628.15% |
| 2011-09-30 | 0.97% |
| 2011-06-30 | -32.52% |
| 2011-03-31 | -9.70% |
| 2010-12-31 | -36.14% |
| 2010-09-30 | 6.45% |
| 2010-06-30 | 42.60% |
| 2010-03-31 | 38.58% |
| 2009-12-31 | -47.62% |
| 2009-09-30 | 10.48% |
| 2009-06-30 | -102.06% |
| 2009-03-31 | 38.10% |
| 2008-12-31 | 13.46% |
| 2008-09-30 | 59.17% |
| 2008-06-30 | -387.23% |
| 2008-03-31 | -19.38% |
| 2007-12-31 | 13.12% |
| 2007-09-30 | 23.61% |
| 2007-06-30 | 24.34% |
